Skip to content

Pushing the barrier: Reducing risks and time to market for prefilled syringes

For coated elastomeric closures, barrier properties alone are no longer enough to meet the needs of biologic drug packaging. Dr Susan Dounce, senior manager, business development and innovation, injection systems, Datwyler Sealing Solutions writes.

Pushing the barrier: Reducing risks and time to market for prefilled syringes
Published: | 3 min read

For coated elastomeric closures, barrier properties alone are no longer enough to meet the needs of biologic drug packaging. Dr Susan Dounce, senior manager, business development and innovation, injection systems, Datwyler Sealing Solutions writes.

Datwyler Sealing Solution

Reducing or eliminating silicone oil is being recognised as a means to mitigate risks and reduce time-to-market. Datwyler’s Omni Flex fluoropolymer coating technology provides numerous advantages and benefits in prefilled syringes beyond barrier properties, especially regarding stability, quality and end user experience.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information